SedaLin By XYMOGEN Overview & Drug Interactions
Check For Interactions With SedaLin
Supplement: SedaLin by XYMOGEN
SedaLin Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
SedaLin(TM)
| Ingredient Group | Proprietary Blend (Herb/Botanical) |
|---|---|
| Category | blend |
Drugs that interact with SedaLin by XYMOGEN
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with SedaLin. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
2 Capsule(s)
|
| Servings per container | 60 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| SedaLin(TM) |
365 mg
|
Proprietary Blend (Herb/Botanical) |
--
|
| Other Ingredients: |
HPMC
Microcrystalline Cellulose
Stearic Acid
Magnesium Stearate
Silicon Dioxide
|
|---|
Label Statments:
| FDA Statement of Identity |
- Dietary Supplement
|
|---|---|
| Suggested/Recommended/Usage/Directions |
- Directions: Take 1-2 capsules nightly, or as directed by your healthcare practitioner.
|
| Precautions |
- Keep out of reach of children.
- CAUTION: Do not take if pregnant or lactating.
- • Pharmaceutical Grade • Professional Use Only
- Do not take if currently taking any prescription medication or receiving medical treatment without consulting your physician.
|
| FDA Disclaimer Statement |
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Storage |
- STORAGE: Keep tightly closed in a cool, dry place.
|
| General Statements |
- Enhanced Sleep Support
- This package is completely recyclable (recycle)
|
| General |
- TC# D4280601 REV. 082310
|
| Brand IP Statement(s) |
- XYMOGEN 2010
- All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.
- SedaLin(TM) is an all-natural herbal blend of Magnolia officinalis and Ziziphus spinosa formulated to improve nighttime sleep through stress and anxiety reduction. The ingredients in SedaLin(TM) have demonstrated effectiveness in relaxing tense muscles and in normalizing nighttime stress hormone levels associated with central nervous system over-stimulation. SedaLin(TM) is non-addictive and may be taken nightly for an indefinite period of time. To achieve maximum effectiveness, SedaLin(TM) should be taken for a minimum of 7 nights in a row and may be taken indefinitely.*
|
| Formulation |
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, sweeteners or preservatives.
|
| Seals/Symbols |
- VEGETABLE CAPSULES
|
Brand Information
See all products by this brand
| Researched, Developed & Distributed by: | |
|---|---|
| Name | XYMOGEN Exclusive Professional Formulas |
| Street Address | 725 S. Kirkman Rd. |
| City | Orlando |
| State | FL |
| ZipCode | 32811 |
| Phone Number | 800-647-6100 |
| Web Address | www.xymogen.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.